Why the study?
Secondary hypertension is more prevalent in patients with difficult-to-treat hypertension or specific clinical features, and its targeted identification and therapy may normalize or improve blood pressure.
Does targeted diagnostics for secondary hypertension improve blood pressure control in patients with resistant or atypical hypertension?
Does targeted diagnostics for secondary hypertension improve blood pressure control in patients with resistant or atypical hypertension?
Targeted diagnostics for secondary hypertension are crucial in patients with resistant or atypical hypertension, as specific therapy can normalize or improve blood pressure.
Supports targeted screening in atypical hypertension; leaves open whether systematic evaluation improves outcomes in prospective studies.
In secondary hypertension, elevated blood pressure is caused by a known and/or potentially treatable underlying disease.Although the prevalence of secondary hypertension depends on the patient population and the thoroughness of applied diagnostic approaches, arterial hypertension is classified in 90 to 95% as primary in nature. In young patients, individuals without a family history of hypertension, late onset of hypertension or worsening of a previous well-controlled hypertension as well as in patients who have a difficult to treat hypertension, the prevalence of secondary hypertension is significantly higher.Because the identification and the specific therapy of secondary hypertension may result in normalisation or improvement of elevated blood pressure in many cases, a targeted diagnostics is of great importance.
No takes yet. Share an insight, caveat, or question.
Sudano et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: